Abeona Therapeutics (ABEO)

• Market cap: $253M
• 1 day: 18.47%
• 5 days: 13.3%
• 1 month: -8.69%
• 3 months: -22.57%
• 6 months: -11.79%
• Year to date: -16.41%
• 1 year: -19.15%
• 5 years: -83.67%
• 10 years: -95.19%
• Sector: Healthcare
• Industry: Biotechnology

About: Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Employees: 136